UBS Exchange Traded Funds offer an investment in a broad-based market with just one transaction, the flexibility of security investments combined with a fund investment and transparency thanks to the reference index.
The UBS ETF – Bloomberg Barclays US Liquid Corporates UCITS ETF sub-fund aims to track, before expenses, the price and income performance of the Bloomberg Barclays US Liquid Corporates Duration Hedged Index Total Return (this sub-fund's "Index").
The sub-fund is a feeder UCITS (the “Feeder Fund”). It invests at least 85% of its net assets in the (USD) A-dis share class of UBS ETF – Bloomberg Barclays US Liquid Corporates UCITS ETF, a sub-fund of the Company (the "Master Fund").
Clients benefit from the flexibility of an exchange-traded investment.
Provides access to this segment of the market with a single transaction.
Optimised risk/return profile thanks to a broad diversification across a range of equity factors and sectors.
The fund offers a high degree of transparency and cost efficiency.
UCITS compliant fund.
This UBS Exchange Traded Fund invests in corporate bonds and may therefore be subject to high fluctuations in value. For this reason, an investment horizon of at least five years and corresponding risk tolerance and capacity are required. All investments are subject to market fluctuations. Every fund has specific risks, which can significantly increase under unusual market conditions. As a result, the net asset value of the fund's assets is directly dependent on the performance of the underlying index. Losses that could be avoided via active management will not be offset.
UBS Exchange Traded Funds
UBS ETF SICAV
UBS Asset Management, Zürich
UBS Fund Management (Luxembourg) S.A.
State Street Bank Luxembourg S.A.
Day of inception
July 31, 2017
Currency of account
Close of financial year
Issue / redemption
Total expense ratio (TER)
Reference Index / Benchmark
Bloomberg Barclays US Liquid Corporates™ Duration hedged Index
twice a year
Net asset value
High - last 12 months
Low - last 12 months
Total product assets in mn
Exchange listing and trading currency
London Stock Exchange
Performance chart (USD-based, as of July 18, 2018)
Indexed, Daily values
Past performance is not a reliable indicator of future results.
Performance (in %, as of July 18, 2018)
The performance shown does not take account of any commissions, entry or exit charges.
These figures refer to the past. Past performance is not a reliable indicator of future results.
Additional fees (e.g. entry or exit fees) may be charged by the Distributor. Please refer to your financial adviser for more details. For a definition of financial terms refer to the glossary available at www.ubs.com/glossary
For marketing and information purposes by UBS. UBS funds under Luxembourg law. Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available in a language required by the local applicable law free of charge from Northern Trust Global Services Limited, Luxembourg Branch, 6, rue Lou Hemmer, L-1748 Senningerberg or from UBS Europe SE, Luxembourg Branch, P.O. Box 2, L-2010 Luxembourg. Barclays US Liquid Corporates UCITS, Barclays Euro Area Liquid Corporate 1-5 Year Index, Barclays US Liquid Corporate 1-5 Year Index and Barclays Emerging Markets USD Sovereign & Agency 3% Country Capped Index (the “Barclays Indices”) are trademarks of Barclays Capital or its affiliates and have been licensed for use in connection with UBS Exchange Traded Funds. UBS Exchange Traded Funds based on Barclays Indices are not sponsored or endorsed by Barclays Capital or its affiliates. Neither Barclays Capital nor its affiliates make any representation regarding the advisability of investing in UBS Exchange Traded Funds. The fund documentation is available free of charge in English and, where relevant, in one of the local language(s) where the fund is registered. Before investing in a product please read the latest prospectus carefully and thoroughly. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not indicated otherwise): UBS Asset Management